Scribd
Upload
49 views15 pages

Administration of Blood and Blood Products

The Administration of Blood and Blood Products Policy at Al Hayah National Hospital aims to ensure the correct administration of blood components to patients, emphasizing safety and compliance with established standards. It outlines responsibilities for medical and nursing staff, procedures for blood transfusion, and protocols for managing adverse reactions. The policy applies to all clinical staff involved in the transfusion process and includes necessary documentation and consent requirements.

Uploaded by

jayver23
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
49 views15 pages

Administration of Blood and Blood Products

The Administration of Blood and Blood Products Policy at Al Hayah National Hospital aims to ensure the correct administration of blood components to patients, emphasizing safety and compliance with established standards. It outlines responsibilities for medical and nursing staff, procedures for blood transfusion, and protocols for managing adverse reactions. The policy applies to all clinical staff involved in the transfusion process and includes necessary documentation and consent requirements.

Uploaded by

jayver23
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 15

ESR

ADMINISTRATION OF
BLOOD AND BLOOD
PRODUCTS
PURPOSE
– The main purpose of the Administration of
Blood and Blood Products Policy is to ensure
that the right patient receives the right blood
component at the right time.

– To ensure that all staff involved in the handling,


prescribing and administration of blood/blood
components are fully conversant with the
standards and procedures for dealing with
blood/blood components at all times.

– To facilitate safe practice within all clinical


areas and ensure the safety of the patient
SCOPE
This policy applies Al Hayah
National Hospital, and applies to
all Clinical staff who is involved in
some stage of the Transfusion
Process.
DEFINITION
• Blood Component: a therapeutic part of blood intended for transfusion

• Blood Product: therapeutic product derived from human blood or plasma


and produced by a manufacturing process.

• Compatibility Label / Tag: tag or label attached to a blood component or


blood product that has been designated for a specific recipient, specifying
information that identifies the blood component or blood product for that
recipient.

• Transfusionist: individual who administers a blood transfusion.

• Vital Signs: the measurement of temperature, pulse, respiration rate and


blood pressure.

• Whole Blood: unaltered anti coagulated blood collected from a donor .


POLICY
• The policy of the Al Hayah National Hospital is to ensure
that blood components and blood products are
transfused to patients for clinically appropriate conditions
with a goal to optimize patient outcomes and ensure blood
components and blood products are used appropriately
according to established standards.

• The decision to transfuse, and the consideration of other


blood management strategies, must be based on a through
clinical assessment of the patient and his/her individual
needs.
POLICY
• Pre-transfusion sample collection must include
positive patient identification process. Blood
products request must include positive patient
identification process and provide a clear
communication to the transfusion service
provider, urgency and dose required. The blood
products request must include the clinical
indication for the transfusion and any special
blood product requirement for the patients.
RESPONSIBILITY

• Chief Medical Director, Director of Nursing- are


responsible for ensuring that the requirements of the
Administration of Blood and Blood products Policy are
effectively managed within their Directorate and that their
staff are aware of, and implement those requirements.

• Head Nurse, Laboratory Supervisor- responsibility to


ensure that staff are made aware of the processes for the
correct administration of blood and blood components.
These procedures should be included in the induction of all
staff who may be involved in the care of the patient. Any
incidents involving the use of blood and blood components
should be investigated and reported to the Supervisor thru
OVR.
RESPONSIBILITY
• Medical Staff- should ensure that they are familiar with the
procedures prescribing; requesting and administration of all blood and
blood components. These policies and procedures include the Consent
policy. Senior medical staff responsible for the supervision and training
of doctors in training should ensure that junior medical staffs are
competent to undertake procedures within this policy.

• Nursing staff- It is the responsibility of every registered nurse given


responsibility of administering and/or observing a patient during their
transfusion that they policy the procedures laid down in this policy. All
staff should report any patient incidents involving the use of Blood or
Blood components via the OVR. The Ward Head Nurse/Supervisor
/Departmental Manager should be informed of the incident.
PROCEDURES
 Informed Consent
 If NAT is not done, indicate in the consent.
 Ordering Blood Component and Blood
Products
 Telephone Request –Emergency Blood
and Blood Products
 Blood Availability
 Cross matching
 Identification of patients by 2 RN
 Sample Bottles must not be pre-labeled
PROCEDURES
 Administration of blood component and blood products.
 Verify signed consent for blood/blood product if present in
patient’s file.
 Check the patient’s identifiers (full names and medical record
number), ID band, prescribed blood product, number of unit,
blood type and cross-matching, blood tag number, expiration
date, ward/unit.
Important: 2 nurse should identify the patient identity and blood
component available.

NOTE: DO NOT START the transfusion if there is not an identical


match. Notify the Blood Transfusion Laboratory.
PROCEDURES
 Transfusion of Blood Component and
Blood Products and monitor the
patient for the first 5 to 15 minutes
after the blood transfusion is
initiated and hourly after 15
minutes.
PROCEDURES
IF ANY ADVERSE TRANSFUSION REACTIONS
ARE OBSERVED:
 THE TRANSFUSION SHALL BE STOPPED
IMMEDIATLEY by clamping the tubing as
close to the IV site as possible. Any remaining
blood component or blood product in the
tubing should not be flushed.
 Lines should be kept open with 0.9% Sodium
Chloride.
 Notify the physician and Blood bank
PROCEDURES
 All blood component and blood product containers with
attached administration set and IV solutions, whether empty
or not, appropriate blood samples and documentation shall be
returned to the Transfusion Laboratory as soon as possible for
follow-up investigation.
 Extract Blood sample and collect urine sample and send to
the laboratory.
 All observed signs and symptoms shall be documented on the
patient’s medical chart /record, the compatibility / label tag
and if applicable the adverse transfusion reaction form.
 Any intervention or action taken shall be documented
FORMS

• Blood transfusion form

• Blood transfusion Checklist

• Blood transfusion monitoring sheet


Question ?

Thank you

You might also like